Denzil Paul

TL;DR: In OSA participants with co-morbid insomnia, CBT-i prior to initiating CPAP treatment improves CPAP use and insomnia symptoms compared to commencing CPAP without CBT -i.

TL;DR: CBTi appears to be a safe and effective treatment in the presence of co-morbid moderate and severe OSA, Nevertheless, COMISA patients treated with CBTi should be monitored closely for increased daytime sleepiness during the initial weeks of bedtime restriction therapy.

TL;DR: CBTi consolidates sleep periods and promotes a 15% decrease in OSA severity in patients with comorbid insomnia and OSA, suggesting that insomnia disorder may exacerbate OSA and provides further support for treating insomnia in the presence of comor bid OSA.

TL;DR: No evidence is found that symptoms of depression, anxiety, or stress impair the effectiveness of CBTi in improving insomnia symptoms in patients with COMISA, and patients with comorbid insomnia with obstructive sleep apnea should be referred for CBTi to treat insomnia and improve subsequent management of their OSA.